These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1065 related articles for article (PubMed ID: 28003153)
1. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. Dempsey C; Rubio Araiz A; Bryson KJ; Finucane O; Larkin C; Mills EL; Robertson AAB; Cooper MA; O'Neill LAJ; Lynch MA Brain Behav Immun; 2017 Mar; 61():306-316. PubMed ID: 28003153 [TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice. Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390 [TBL] [Abstract][Full Text] [Related]
3. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317 [TBL] [Abstract][Full Text] [Related]
5. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages. Finucane OM; Sugrue J; Rubio-Araiz A; Guillot-Sestier MV; Lynch MA Sci Rep; 2019 Mar; 9(1):4034. PubMed ID: 30858427 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease. Zhang Y; Zhao Y; Zhang J; Yang G Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691 [TBL] [Abstract][Full Text] [Related]
7. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice. Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728 [TBL] [Abstract][Full Text] [Related]
8. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation. Yaw ACK; Chan EWL; Yap JKY; Mai CW J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974 [TBL] [Abstract][Full Text] [Related]
9. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease. Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750 [TBL] [Abstract][Full Text] [Related]
10. Chronic Amyloid β Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3. Fekete C; Vastagh C; Dénes Á; Hrabovszky E; Nyiri G; Kalló I; Liposits Z; Sárvári M Neuroscience; 2019 May; 405():35-46. PubMed ID: 29522854 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death. Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization. Yang X; Sun A; Kong L; Yang X; Zhao X; Wang S Int Immunopharmacol; 2024 Aug; 137():112374. PubMed ID: 38851162 [TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway. Wang A; Zhong G; Ying M; Fang Z; Chen Y; Wang H; Wang C; Liu C; Guo Y Neuropharmacology; 2024 Oct; 257():110063. PubMed ID: 38972372 [TBL] [Abstract][Full Text] [Related]
15. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy. Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320 [TBL] [Abstract][Full Text] [Related]
16. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats. Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832 [TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo. Sui X; Yang J; Zhang G; Yuan X; Li W; Long J; Luo Y; Li Y; Wang Y Toxicology; 2020 Feb; 432():152392. PubMed ID: 32014472 [TBL] [Abstract][Full Text] [Related]
18. TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer's Disease. Zhu M; Liu Y; Chen C; Chen H; Ni W; Song Y; Lv B; Hua F; Cui G; Zhang Z J Alzheimers Dis; 2024; 99(3):911-925. PubMed ID: 38728187 [TBL] [Abstract][Full Text] [Related]